-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Initiates Coverage On Dianthus Therapeutics with Overweight Rating, Announces Price Target of $135

Benzinga·03/19/2026 13:03:45
Listen to the news
Wells Fargo analyst Sadia Rahman initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Overweight rating and announces Price Target of $135.